CD127low T Regulatory Cells and HTLV-1 Infection
Author Information
Author(s): Michaëlsson Jakob, Barbosa Hugo Marcelo R, Jordan Kimberley A, Chapman Joan M, Brunialti Milena KC, Neto Walter Kleine, Nukui Youko, Sabino Ester C, Chieia Marco Antonio, Oliveira Acary Souza Bulle, Nixon Douglas F, Kallas Esper G
Primary Institution: University of California, San Francisco
Hypothesis
HTLV-1 compromises TReg cell function, resulting in higher T cell activation, which contributes to HAM/TSP development.
Conclusion
The study suggests that TReg cells may be subverted in HAM/TSP patients, contributing to increased T cell activation and providing potential therapeutic targets.
Supporting Evidence
- HTLV-I drives activation, spontaneous IFNγ production, and proliferation of CD4+ T cells.
- HAM/TSP patients have a significantly lower proportion of CTLA-4+ TReg cells compared to healthy controls.
- The proportion of CD127low TReg cells correlated inversely with HTLV-1 proviral load.
Takeaway
This study found that a type of immune cell called TReg cells is less frequent in patients with a specific disease caused by a virus, which might help explain why their immune system is overactive.
Methodology
Blood samples were collected, PBMC were isolated, and flow cytometry was used to assess TReg cell frequency and activation markers.
Potential Biases
Potential bias due to the cross-sectional design and limited phenotypic markers for TReg identification.
Limitations
The study was cross-sectional with a limited number of patients in each group.
Participant Demographics
Participants included healthy controls, HTLV-1 seropositive asymptomatic individuals, and HAM/TSP patients.
Statistical Information
P-Value
0.017
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website